Due to its anti-inflammatory activity and marked analgesic proprieties, as well as its ability to activate PPAR-α and influence the endocannabinoid system, um-PEA is a good candidate for the management of neuropathic pain and mood disorders produced by chemotherapy. This evidence concerns the gene PPARA and mood disorder.